129 related articles for article (PubMed ID: 4106003)
1. [Clinical experiences with urokinase].
Fischer M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 95(2):145-57. PubMed ID: 4106003
[No Abstract] [Full Text] [Related]
2. [Thromboembolism and fibrinolytic therapy].
Heinrichs C
Z Arztl Fortbild (Jena); 1978 Apr; 72(8):357-65. PubMed ID: 695726
[No Abstract] [Full Text] [Related]
3. [When is fibrinolytic therapy indicated?].
Woitinas F
Med Klin; 1980 Feb; 75(3):98-107. PubMed ID: 6990218
[No Abstract] [Full Text] [Related]
4. [Thrombolytic treatment of thromboembolytic conditions].
Gormsen J
Ugeskr Laeger; 1966 Oct; 128(42):1235-45. PubMed ID: 4231392
[No Abstract] [Full Text] [Related]
5. The influence of inhibitors of plasmin and plasminogen activation on the streptokinase-induced fibrinolytic state.
Spöttl F; Holzknecht F
Thromb Diath Haemorrh; 1970 Oct; 24(1):101-12. PubMed ID: 4249466
[No Abstract] [Full Text] [Related]
6. [Clinical use of thrombolytic agents].
Laprevote-Heully MC; Lambert H; Larcan A
Agressologie; 1983 Nov; 24(11):559-65. PubMed ID: 6367511
[No Abstract] [Full Text] [Related]
7. [Fibrinolysis and thrombolytic therapy under laboratory control].
Osten W
Med Lab (Stuttg); 1966 May; 19(5):108-13 contd. PubMed ID: 5982109
[No Abstract] [Full Text] [Related]
8. [Treatment of thromboembolic conditions with thrombolytics and anticoagulants].
Wojczuk J
Wiad Lek; 1974 May; 27(10):877-82. PubMed ID: 4134634
[No Abstract] [Full Text] [Related]
9. [The thrombolytic medications].
Rignault D
Presse Med (1893); 1969 Jan; 77(2):55-8. PubMed ID: 4239477
[No Abstract] [Full Text] [Related]
10. [Pharmacological potentials for activating the fibrinolytic system].
Markwardt F
Z Gesamte Inn Med; 1984 May; 39(10):209-13. PubMed ID: 6380126
[TBL] [Abstract][Full Text] [Related]
11. [Behavior of human plasmin inhibitors in intravascularly increased fibrinolytic activity].
Fischer M
Thromb Diath Haemorrh; 1970 Jun; 23(3):513-52. PubMed ID: 4247030
[No Abstract] [Full Text] [Related]
12. Clinical and laboratory experiences with selective thrombolysis.
Bookstein JJ
Ann Radiol (Paris); 1984; 27(4):322-3. PubMed ID: 6234843
[No Abstract] [Full Text] [Related]
13. [Disseminated intravascular coagulation].
Amir J
Harefuah; 1972 Jul; 83(1):29-32. PubMed ID: 4264530
[No Abstract] [Full Text] [Related]
14. Urokinase evaluated with the experimental radioactive embolus.
Hume M
Thromb Diath Haemorrh; 1967 May; 17(3-4):405-11. PubMed ID: 4231948
[No Abstract] [Full Text] [Related]
15. [Current situation and developmental trends in the field of thrombolytic agents].
Markwardt F
Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(1):5-8. PubMed ID: 4134480
[No Abstract] [Full Text] [Related]
16. Measurement during fibrinolytic therapy.
McNicol GP
Proc R Soc Med; 1969 Nov; 62(11 Part 1):1131-3. PubMed ID: 5356869
[No Abstract] [Full Text] [Related]
17. Fibrinolysis.
Sherry S
Annu Rev Med; 1968; 19():247-68. PubMed ID: 4172727
[No Abstract] [Full Text] [Related]
18. Thrombolytic therapy in the management of venous thromboembolism.
Wenger NK
J Med Assoc Ga; 1983 Feb; 72(2):121-3. PubMed ID: 6833916
[No Abstract] [Full Text] [Related]
19. Thrombolytic therapy.
Jacobs J
N C Med J; 1984 May; 45(5):296-301. PubMed ID: 6587192
[No Abstract] [Full Text] [Related]
20. [Consumption coagulopathies in childhood. I. Physiopathology, diagnosis, therapy].
Braun W; Giertler U; Schwela S; Weinel P; Weinmann G; Zuber U
Kinderarztl Prax; 1973 Nov; 41(11):469-75. PubMed ID: 4786244
[No Abstract] [Full Text] [Related]
[Next] [New Search]
